Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents

415Citations
Citations of this article
79Readers
Mendeley users who have this article in their library.
Get full text

References Powered by Scopus

Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study

5020Citations
N/AReaders
Get full text

Tamoxifen for early breast cancer: An overview of the randomised trials

3825Citations
N/AReaders
Get full text

Design of the Women's Health Initiative clinical trial and observational study

2299Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Fluorine in pharmaceutical industry: Fluorine-containing drugs introduced to the market in the last decade (2001-2011)

4144Citations
N/AReaders
Get full text

Principles for modulation of the nuclear receptor superfamily

1006Citations
N/AReaders
Get full text

Modern synthetic methods for fluorine-substituted target molecules

726Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Jordan, V. C. (2003, March 27). Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents. Journal of Medicinal Chemistry. https://doi.org/10.1021/jm020450x

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 35

64%

Professor / Associate Prof. 10

18%

Researcher 10

18%

Readers' Discipline

Tooltip

Chemistry 21

43%

Agricultural and Biological Sciences 11

22%

Biochemistry, Genetics and Molecular Bi... 11

22%

Medicine and Dentistry 6

12%

Article Metrics

Tooltip
Mentions
References: 3

Save time finding and organizing research with Mendeley

Sign up for free